INTRODUCTION
============

The rate of cleft lip and cleft palate occurrence is roughly 1 in 700 \[[@b1-aps-2019-00395]\], and the global prevalence of infantile hemangioma is approximately 4%--5% \[[@b2-aps-2019-00395]\]. While these are relatively common deformities, infantile hemangioma on the cleft side of the cleft lip is extremely rare worldwide \[[@b3-aps-2019-00395]-[@b5-aps-2019-00395]\].

In accordance with the general cleft lip treatment guidelines, we performed cleft lip repair in a patient with infantile hemangioma on the cleft side of the cleft lip at 3 months after birth. The patient has received regular follow-up for the past 18 years.

CASE
====

This study was approved by the Ethics Committee of Pusan National University Hospital (IRB No. 2002-016-088). Informed consent was obtained for the use of patient data. The male patient was born at 39 gestational weeks with a birth weight of 2,500 g. Based on a physical examination, he was diagnosed with a left unilateral complete cleft lip with an alveolar cleft and a submucous cleft palate. Multiple infantile hemangiomas were found throughout his body, with no notable abnormalities observed in a chromosomal analysis.

Of particular note, the patient had infantile hemangiomas on the upper lip and lower lip, helix of the right ear, back, and left shoulder. The hemangioma on the upper lip was on the lateral segment of the cleft side ([Fig. 1](#f1-aps-2019-00395){ref-type="fig"}).

In accordance with the general guidelines for the treatment of cleft lip, cleft lip repair was performed at 3 months after birth. The Millard modified rotation-advancement technique, which involves the use of a lower small triangular flap, was chosen. The infantile hemangioma was ignored in the design, and unclear landmarks were determined. The operative field was infiltrated with 1:100,000 epinephrine-mixed lidocaine, and an incision was made with a \#15 scalpel. Sharp-tipped tissue scissors were used to separate the orbicularis oculi muscle from the skin and mucosa. The excised hemangioma was sent for a permanent biopsy, and the orbicularis oculi muscle, skin, and mucosa were repaired. As the infantile hemangioma was ignored in the design, it remained present at the repair site.

There was no excessive intraoperative bleeding, and blood transfusion was not needed. The excised tissue was confirmed to be an infantile hemangioma upon histopathologic examination. The patient showed no abnormalities during recovery, and some residue of the infantile hemangioma remained at the repair site in the upper lip vermilion ([Fig. 2](#f2-aps-2019-00395){ref-type="fig"}).

Intravelar veloplasty was performed for the submucous cleft palate when the patient was 22 months old, and the patient was diagnosed with strabismus at the age of 3 years. At 5 years, the patient was diagnosed with mental retardation, right sensorineural hearing loss, and total hearing loss on the right side. At 7 years, the patient underwent correction for a cleft lip nose deformity ([Fig. 3](#f3-aps-2019-00395){ref-type="fig"}). At 9 years, he was diagnosed with a language disorder due to cleft palate and hearing impairment. At 11 years, an iliac bone graft was performed for the alveolar cleft. The residual infantile hemangioma in the repair site of the upper lip vermilion was involuted by the time the patient was 5 years old, and only a normal degree of scarring from the cleft lip repair was present. At the same time, the infantile hemangiomas in the helix of the right ear, back, and left shoulder were found to be completely involuted without any scarring ([Fig. 4](#f4-aps-2019-00395){ref-type="fig"}). The patient has received regular follow-up, and at 18 years old, he has no related problems other than a red scar on the lower lip ([Fig. 5](#f5-aps-2019-00395){ref-type="fig"}).

DISCUSSION
==========

Infantile hemangioma is characterized by a growth phase and an involution phase, and serial observation is therefore recommended as the general treatment for uncomplicated infantile hemangiomas. However, individualized approaches may be utilized depending on the size, morphology, or location of the lesion, the presence or possibility of complications, the potential for scarring or disfigurement, the patient's age, and the rate of growth/involution \[[@b6-aps-2019-00395],[@b7-aps-2019-00395]\]. Recent clinical guidelines published by the American Academy of Pediatrics reflect these trends and emphasize the importance of early intervention for infantile hemangioma \[[@b8-aps-2019-00395]\].

An important determinant of the aesthetic results of cleft lip repair is the timing of the repair. Definitive cleft lip repair is often performed at 3--6 months of age in consideration of underlying medical issues, the need to minimize the risks of anesthesia, and the completion of pre-surgical orthopedic treatment \[[@b9-aps-2019-00395]\]. Infantile hemangioma proceeds through a rapid growth phase for several months after birth, and slow growth may continue until 6--12 months after birth \[[@b10-aps-2019-00395]\]. From then, the tumor shows improvement until 3--4 years of age and then ceases to improve \[[@b11-aps-2019-00395]\]. Therefore, the opportunity for well-timed general cleft lip repair may be missed if repair is delayed until the infantile hemangioma enters the involution phase.

Some factors that hinder early surgical intervention for infantile hemangiomas include anesthetic risks and the risk of bleeding due to the highly vascular nature of the tumor \[[@b12-aps-2019-00395]\]. However, surgery may be a desirable option if early intervention makes later reconstruction easier \[[@b12-aps-2019-00395]\]. Excising the hemangioma and repairing the cleft lip in early phases may also reduce cleft lip-related deformity. These recommendations are in line with recent trends in infantile hemangioma treatment. It is difficult to obtain optimal aesthetic results from cleft lip repair when it is delayed until after the infantile hemangioma is involuted. Further, potential psychosocial impairment among patients and caregivers resulting from delaying surgery until involution also cannot be ignored.

Yavuzer et al. \[[@b3-aps-2019-00395]\] reported an early, single-stage cleft lip correction with partial hemangioma excision in a 3-month-old boy with a left unilateral complete cleft lip complicated by a hemangioma involving the lip, columella, and nasal tip. In typical cases of cleft lip, the philtral segment is shorter on the cleft side than on the non-cleft side, but in this case, due to tissue hypertrophy, the cleft-side philtrum was longer. Due to this finding, a back cut was not made on the columellar base. Instead, a 2-mm skin triangle was excised to equalize the non-cleft and non-hemangioma sides. In this procedure, the hemangioma in the repair site of the upper lip was totally excised. The recovery period was uneventful and without complications, and at 6-month followup, the lip showed satisfactory healing. In our case, the hemangioma showed less protrusion, and more of the anatomical landmarks of the cleft side of the upper lip were preserved. The infantile hemangioma was ignored in the design of the procedure, and unclear landmarks were determined. As a result, the hemangioma remained present at the repair site. No postoperative complications were observed at the repair site. Like the lesions at the other sites, the hemangioma at the repair site was involuted by the age of 5 years.

Bleeding risk is another factor that hinders surgical intervention for infantile hemangiomas. In our case, we performed cleft lip repair with adequate preparation for massive bleeding. However, no excessive bleeding occurred, and blood transfusion was not needed.

Infantile hemangiomas requiring lip repair for unilateral complete cleft lip are extremely rare, and no surgical guidelines have been established for this condition. In these cases, delaying lip repair until the infantile hemangioma is involuted may not lead to the best aesthetic outcome, and such a delay may also cause psychosocial impairment in patients and caregivers.

Therefore, we believe that general cleft lip repair produces good outcomes even in cases involving hemangiomas on the cleft side.
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![Pediatric patient aged 3 months\
Infantile hemangiomas in the (A) lateral segment of the cleft side of the upper lip and lower lip, (B) helix of the right ear, and (C) left shoulder.](aps-2019-00395f1){#f1-aps-2019-00395}

![Six months after lip repair\
Residual infantile hemangioma was present in the repair site of the upper lip vermilion, and infantile hemangioma remained present at the lower lip.](aps-2019-00395f2){#f2-aps-2019-00395}

![Seven years after lip repair\
Image taken immediately after correction of a cleft lip nose deformity. The infantile hemangioma at the repair site of the upper lip vermilion and lower lip was still not involuted.](aps-2019-00395f3){#f3-aps-2019-00395}

![Eleven years after lip repair\
The hemangioma had been lost in the repair site of the upper lip vermilion. However, the infantile hemangioma on the lower lip was still not involuted.](aps-2019-00395f4){#f4-aps-2019-00395}

![Eighteen years after lip repair\
Only a normal degree of cleft lip repair scarring could be observed in the upper lip repair site. On the lower lip, reddish pigmentation could still be observed.](aps-2019-00395f5){#f5-aps-2019-00395}

[^1]: This article was presented at the Plastic Surgery The Meeting 2019 on September 20-23, 2019, in San Diego, CA, USA.
